Topic: Brca Gene

New research suggests AI is significantly more accurate than traditional models at predicting breast cancer risk by analyzing mammogram biomarkers. This is compared to the 2015 promotion of the BRCA gene test by Angelina Jolie, which led to a surge in preventative mastectomies. The shift toward AI-based diagnostics is viewed skeptically as a potential new marketing cycle for the medical industry.

Following a lawsuit against HHS, documents revealed that the MMR vaccine was tested on only 800 children for a period of 42 days. In a separate medical discussion, the hosts share a story of a woman who underwent a double mastectomy based on a false positive DNA test for the BRCA gene. They warn of the dangers of relying on single-source genetic testing for major medical decisions.

The FDA has approved 23andMe to provide direct-to-consumer genetic testing for three specific mutations linked to breast and ovarian cancer. Dr. David Agus warns that while these tests are now affordable, they only cover a fraction of the over 1,000 possible mutations in the BRCA1 and BRCA2 genes. A negative result on a 23andMe test may provide a false sense of security for individuals who carry other high-risk mutations.

Angelina Jolie wrote an op-ed in the New York Times about her decision to have her ovaries removed following a previous preventative double mastectomy. Jolie carries the BRCA1 gene mutation, which increases the risk of breast and ovarian cancer. The hosts describe this trend of "preventative" surgery as a form of "self-mutilation" and question the medical ethics of removing healthy organs based on genetic probability.